Nitroglycerin: Clinical Trials

26 trials of Nitroglycerin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 4 unknown, 3 terminated. 26 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 326Completed 19, Unknown 4, Terminated 3
Phase 28Completed 4, Terminated 3, Unknown 1

Follow Nitroglycerin: new trials by email Literature Review of Nitroglycerin trials Research Report on Nitroglycerin

Trials (filtered) newest first · largest first

All 26 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
High Versus Low Dose Nitroglycerin in Acute Pulmonary Edema
Nitroglycerin - Pulmonary Edema
Phase 2 / Phase 3UnknownAlexandria University602023-11-102023-10-30
Effect of Topically-applied Milrinone or Nitroglycerin on Internal Mammary Artery Free Flow
The topical application of a vasodilator on the LIMA graft - Internal Mammary Artery Syndrome, Vasodilation
Phase 3CompletedDamascus University462022-01-012026-03-19
Effect of Evolocumab on Coronary Atherosclerosis
Evolocumab, 18F-NaF PET, CCTA - Cardiovascular Disease, Hyperlipidemia
Phase 3CompletedCedars-Sinai Medical Center552019-03-192024-07-17
Clinical Trial Using Topically Applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction
MED2005 - Erectile Dysfunction
Phase 3CompletedFutura Medical Developments Ltd.10052018-11-012022-03-02
Intraarterial Nitroglycerin Versus Nicardipine and Radial Artery Occlusion
Nitroglycerin - Radial Artery Injury at Wrist and Hand Level, Occlusion of Artery
Phase 3CompletedHermina Heart Center Kemayoran6002018-06-042019-06-04
The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems
Nitroglycerin, Negative Pressure Wound Therapy/ Wound VAC, Fluorescent Angiography with indocyanine-green (not to exceed 5mg/kg) - Perfusion; Complications
Phase 2 / Phase 3TerminatedWake Forest University Health Sciences172018-01-302020-05-21
Prevention of Radial Artery Occlusion After Transradial Access Using Nitroglycerin
Nitroglycerin I, Placebo I, Nitroglycerin II - Injury of Radial Artery
Phase 3CompletedInstituto de Cardiologia de Santa Catarina20402017-07-062024-12-09
Nitroglycerin Skin Patches for Facilitating Cervical Ripening: A Randomized Controlled Trial
Nitroderm TTS, Dinoprostone - Induction of Labor Affected Fetus / Newborn
Phase 2 / Phase 3CompletedAin Shams Maternity Hospital1002016-12-012017-10-25
Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial
Nitroglycerin - Total Atherosclerotic Occlusion of Radial Artery
Phase 3UnknownTotal Cardiovascular Solutions24002016-03-012019-09-17
Randomized Clinical Trial Comparing Transradial Catheterization With or Without Spasmolytic Drugs
Nitroglycerin, Placebo - Cardiac Catheterisation
Phase 3CompletedInstituto de Cardiologia de Santa Catarina3282015-02-012019-05-31
Study to Evaluate is ECV Success is Improved and the Side Effects Reduced With the Use of IV NTGL Versus Terbutaline
Intravenous Terbutaline, Intravenous Nitroglycerine - External Cephalic Version
Phase 2 / Phase 3TerminatedYaakov Beilin62014-07-012017-06-14
Investigation Into the Role of GTN & RIPC in Cardiac Surgery
Remote ischaemic preconditioning, IV Normal saline, IV Glyceryl trinitrate 2-5ml/h - Myocardial Reperfusion Injury
Phase 3CompletedUniversity College, London1922014-01-012019-09-25
Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED)
Low-dose rtPA, Standard-dose rtPA, Intensive blood pressure (BP) lowering - Ischemic Stroke, High Blood Pressure
Phase 3CompletedThe George Institute45872012-03-012021-10-13
Topical Radial Artery Vasodilation
Nitroglycerin and lidocaine, Placebo - Cardiac Catheterization, Spasm
Phase 2 / Phase 3CompletedUniversity of California, San Francisco862010-07-012018-09-25
Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms
0.9% nitroglycerin in TAM cream, vehicle cream - Raynaud Disease
Phase 3UnknownMediQuest Therapeutics1002009-06-012010-07-20
The Effects of Glucocorticoids on Mortality and Renal Function in Patients With Acute Decompensated Heart Failure
glucocorticoid, standard care - Heart Failure
Phase 2 / Phase 3CompletedHebei Medical University1022009-01-012012-02-22
Perianal Versus Endoanal Application of Glyceryl Trinitrate 0.4% Ointment for Chronic Anal Fissure
Rectogesic® (glyceryl trinitrate 0.4% ointment) - Chronic Anal Fissure
Phase 3CompletedHospital General Universitario Elche602009-01-012010-05-28
Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO)
Clevidipine, Standard of Care IV antihypertensive - Hypertension, Heart Failure
Phase 3CompletedThe Medicines Company1172008-12-012014-08-29
A Study of a Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon
Nitroglycerin, Topical AmphiMatrix - Raynaud's Disease, Raynaud's Disease Secondary to Scleroderma
Phase 3UnknownMediQuest Therapeutics2002007-12-012010-02-05
A Study to Determine the Effect of Nitroglycerin Ointment 0.4% (Cellegesic) on the Pain Associated With Chronic Anal Fissures
Cellegesic, Placebo - Fissure in Ano, Pain
Phase 3CompletedForest Laboratories2482007-08-012016-11-03

Showing 20 of 26. Sign in to see all of them.

Conditions studied

Raynaud Disease (5)  ·  Scleroderma, Diffuse (4)  ·  Hypertension (3)  ·  Spasm (3)  ·  Aneurysm (2)  ·  Autoimmune Diseases (2)  ·  Cardiovascular Diseases (2)  ·  Fissure in Ano (2)  ·  Heart Failure (2)  ·  Arterial Occlusive Diseases (1)  ·  Breast Neoplasms (1)  ·  Coronary Disease (1)  ·  Erectile Dysfunction (1)  ·  Heart Diseases (1)  ·  Hyperlipidemias (1)

Sponsors

MediQuest Therapeutics (5)  ·  Instituto de Cardiologia de Santa Catarina (2)  ·  The Medicines Company (2)  ·  Ain Shams Maternity Hospital (1)  ·  Alexandria University (1)  ·  All India Institute of Medical Sciences (1)  ·  Cedars-Sinai Medical Center (1)  ·  Damascus University (1)  ·  Forest Laboratories (1)  ·  Futura Medical Developments Ltd. (1)  ·  Hebei Medical University (1)  ·  Hermina Heart Center Kemayoran (1)  ·  Hospital General Universitario Elche (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  The George Institute (1)

Countries

United States (11)  ·  Brazil (2)  ·  Egypt (2)  ·  India (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  France (1)  ·  Georgia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Indonesia (1)

Top investigators

Roberto L da Silva, MD (2)  ·  Abdelrahman Hemeda, Resident (1)  ·  Ahmed S. Abd El-Hamid, Doctorate (1)  ·  Andrew Boyle, MBBS, PhD (1)  ·  Antonio Arroyo, PhD (1)  ·  Carin Dugowson, MD, MPH (1)  ·  Craig S Anderson, MD (1)  ·  Daniel S. Berman, MD (1)  ·  Derek Yellon, PhD DSc FRCP (1)  ·  Gemma Clark (1)  ·  Ivo A Pestana, MD (1)  ·  Jan Ohrstrom, PhD (1)  ·  Jeff Gregory, MD (1)  ·  Kunshen Liu, MD (1)

Results publications

PMID 15916656, PMID 16580291, PMID 18806012, PMID 21678363, PMID 22810476, PMID 23582415, PMID 23815124, PMID 25179153, PMID 26412308, PMID 27161018, PMID 28599068, PMID 28619989, PMID 28739832, PMID 28973174, PMID 29185557, PMID 29402064, PMID 29571842, PMID 29777016, PMID 30266885, PMID 30739745, PMID 30760277, PMID 30961463, PMID 31812956, PMID 31822251, PMID 31969072, PMID 32568636, PMID 32640944, PMID 33031175, PMID 33069172, PMID 33526633, PMID 33536271, PMID 34096413, PMID 34702064, PMID 36820100, PMID 36939933, PMID 39258531, PMID 39541551, PMID 39861441, PMID 40177745, PMID 40178463, PMID 41131698, PMID 41192975, PMID 42644244

NIH funding

R01HL028843 (1)